ISTA » Topics » 4. Stockholders Equity

These excerpts taken from the ISTA 10-K filed Feb 23, 2009.

4. Stockholders’ Equity

FACE="Times New Roman" SIZE="2">Common and Preferred Stock

In June 2006, the Company issued an aggregate of $40.0 million in
principal amount of our senior subordinated convertible notes, bearing 8% interest per annum payable quarterly in cash in arrears which began October 1, 2006. The notes were scheduled to mature in June 2011 and were convertible, at any time
following their issuance, into shares of the Company’s common stock at a conversion price of $7.63 per share, subject to anti-dilution adjustments. On September 26, 2008, the Company repaid all of the outstanding principal amount and
interest on the senior subordinated convertible notes.

In June 2007, the Company entered into definitive agreements with institutional
accredited investors with respect to the private placement of 5,250,000 shares of its common stock at a purchase price of $7.00 per share, resulting in gross proceeds of approximately $36.7 million before payment of placement agent fees and offering
expenses.

At December 31, 2008 and 2007, the Company had 5,000,000 shares of preferred stock authorized at a $0.001 par value and no
shares were issued and outstanding.

4. Stockholders’ Equity

FACE="Times New Roman" SIZE="2">Common and Preferred Stock

In June 2006, the Company issued an aggregate of $40.0 million in
principal amount of our senior subordinated convertible notes, bearing 8% interest per annum payable quarterly in cash in arrears which began October 1, 2006. The notes were scheduled to mature in June 2011 and were convertible, at any time
following their issuance, into shares of the Company’s common stock at a conversion price of $7.63 per share, subject to anti-dilution adjustments. On September 26, 2008, the Company repaid all of the outstanding principal amount and
interest on the senior subordinated convertible notes.

In June 2007, the Company entered into definitive agreements with institutional
accredited investors with respect to the private placement of 5,250,000 shares of its common stock at a purchase price of $7.00 per share, resulting in gross proceeds of approximately $36.7 million before payment of placement agent fees and offering
expenses.

At December 31, 2008 and 2007, the Company had 5,000,000 shares of preferred stock authorized at a $0.001 par value and no
shares were issued and outstanding.

4. Stockholders’ Equity

FACE="Times New Roman" SIZE="2">Common and Preferred Stock

In June 2006, the Company issued an aggregate of $40.0 million in
principal amount of our senior subordinated convertible notes, bearing 8% interest per annum payable quarterly in cash in arrears which began October 1, 2006. The notes were scheduled to mature in June 2011 and were convertible, at any time
following their issuance, into shares of the Company’s common stock at a conversion price of $7.63 per share, subject to anti-dilution adjustments. On September 26, 2008, the Company repaid all of the outstanding principal amount and
interest on the senior subordinated convertible notes.

In June 2007, the Company entered into definitive agreements with institutional
accredited investors with respect to the private placement of 5,250,000 shares of its common stock at a purchase price of $7.00 per share, resulting in gross proceeds of approximately $36.7 million before payment of placement agent fees and offering
expenses.

At December 31, 2008 and 2007, the Company had 5,000,000 shares of preferred stock authorized at a $0.001 par value and no
shares were issued and outstanding.

This excerpt taken from the ISTA 10-K filed Mar 7, 2008.

4. Stockholders’ Equity

STYLE="margin-top:6px;margin-bottom:0px">Common and Preferred Stock

In January 2005,
the Company sold, under a universal shelf registration statement in an underwritten public offering, 6,325,000 shares of common stock to certain investors for $56.2 million.

STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%">In June 2006, the Company issued an aggregate of $40.0 million in principal amount of our senior subordinated convertible notes, bearing 8% interest per
annum payable quarterly in cash in arrears which began October 1, 2006. The notes mature in June 2011 and are convertible, at any time following their issuance, into shares of our common stock at a conversion price of $7.63 per share, subject
to anti-dilution adjustments. At December 31, 2007, the notes are convertible into 5,242,470 shares.

In June 2007, the Company
entered into definitive agreements with institutional accredited investors with respect to the private placement of 5,250,000 shares of its common stock at a purchase price of $7.00 per share, resulting in gross proceeds of approximately $36.7
million before payment of placement agent fees and offering expenses. As a result of the issuance of the shares in the private placement, the conversion price of the Company’s outstanding senior subordinated convertible notes issued in June
2006 was adjusted from $7.75 to $7.63 pursuant to the terms and conditions of the notes.

 


F-17







Table of Contents



ISTA PHARMACEUTICALS, INC.

ALIGN="center">NOTES TO CONSOLIDATED FINANCIAL STATEMENTS—(Continued)

 


At December 31, 2007 and 2006, the Company had 5,000,000 shares of preferred stock authorized at
a $0.001 par value and no shares were issued and outstanding.

Wikinvest © 2006, 2007, 2008, 2009, 2010, 2011, 2012. Use of this site is subject to express Terms of Service, Privacy Policy, and Disclaimer. By continuing past this page, you agree to abide by these terms. Any information provided by Wikinvest, including but not limited to company data, competitors, business analysis, market share, sales revenues and other operating metrics, earnings call analysis, conference call transcripts, industry information, or price targets should not be construed as research, trading tips or recommendations, or investment advice and is provided with no warrants as to its accuracy. Stock market data, including US and International equity symbols, stock quotes, share prices, earnings ratios, and other fundamental data is provided by data partners. Stock market quotes delayed at least 15 minutes for NASDAQ, 20 mins for NYSE and AMEX. Market data by Xignite. See data providers for more details. Company names, products, services and branding cited herein may be trademarks or registered trademarks of their respective owners. The use of trademarks or service marks of another is not a representation that the other is affiliated with, sponsors, is sponsored by, endorses, or is endorsed by Wikinvest.
Powered by MediaWiki